Highlights: burden of venous thromboembolism and role of extended-duration thromboprophylaxis in acute medically ill patients

被引：0
|
作者：
不详
机构：
来源：
EUROPEAN HEART JOURNAL SUPPLEMENTS | 2018年 / 20卷 / 0E期
关键词：
APEX TRIAL; BETRIXABAN; RISK; PREVENTION; ENOXAPARIN; EVENTS; VTE;
D O I：
10.1093/eurheartj/suy018
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E3 / E5
页数：3
相关论文
共 50 条
  • [1] Reducing the burden of venous thromboembolism in the acute medically ill population with extended-duration thromboprophylaxis
    Ageno, Walter
    Hunt, Beverley J.
    [J]. EUROPEAN HEART JOURNAL SUPPLEMENTS, 2018, 20 (0E) : E6 - E11
  • [2] Extended-Duration Thromboprophylaxis Among Acute Medically Ill Patients: An Unmet Need
    Korjian, Serge
    Daaboul, Yazan
    Halaby, Rim
    Goldhaber, Samuel Z.
    Cohen, Alexander T.
    Singh, Kiran
    Susheela, Ammu T.
    Harrington, Robert A.
    Hull, Russell D.
    Hernandez, Adrian F.
    Gibson, C. Michael
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2016, 21 (03) : 227 - 232
  • [3] A clinical focus on the use of extended-duration thromboprophylaxis in medically ill patients
    Snoga, Jenna L.
    Benitez, Rebekah M.
    Kim, Subin
    Creager, Olivia
    Lusk, Kathleen A.
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2021, 78 (12) : 1057 - 1065
  • [4] Thromboprophylaxis in medically ill patients at risk for venous thromboembolism
    Burleigh, Edward
    Wang, Cheng
    Foster, David
    Heller, Sivana
    Dunn, Dennis
    Safavi, Kaveh
    Griffin, Brian
    Smith, Jeff
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2006, 63 : S23 - S29
  • [5] Direct oral anticoagulants for extended-duration thromboprophylaxis in hospitalized medically ill patients: are we there yet?
    Majed S. Al Yami
    Osamah M. Alfayez
    Sawsan M. Kurdi
    Razan Alsheikh
    [J]. Journal of Thrombosis and Thrombolysis, 2017, 44 : 1 - 8
  • [6] Direct oral anticoagulants for extended-duration thromboprophylaxis in hospitalized medically ill patients: are we there yet?
    Al Yami, Majed S.
    Alfayez, Osamah M.
    Kurdi, Sawsan M.
    Alsheikh, Razan
    [J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2017, 44 (01) : 1 - 8
  • [7] Effect of extended duration of thromboprophylaxis for medically ill patients
    Wang, Xing
    Chen, Yuqi
    Wen, Dingke
    You, Chao
    Ma, Lu
    [J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2023, 113 : 22 - 30
  • [8] Effect of extended-duration thromboprophylaxis on venous thromboembolism and major bleeding among acutely ill hospitalized medical patients: a bivariate analysis
    Chi, G.
    Nafee, T.
    Korjian, S.
    Daaboul, Y.
    Harrington, R. A.
    Goldhaber, S. Z.
    Hull, R. D.
    Gold, A.
    Cohen, A. T.
    Gibson, C. M.
    [J]. EUROPEAN HEART JOURNAL, 2017, 38 : 1204 - 1205
  • [9] Extended-Duration Betrixaban Reduces the Risk of Rehospitalization Associated With Venous Thromboembolism Among Acutely Ill Hospitalized Medical Patients Findings From the APEX Trial (Acute Medically Ill Venous Thromboembolism Prevention With Extended Duration Betrixaban Trial)
    Chi, Gerald
    Yee, Megan K.
    Amin, Alpesh N.
    Goldhaber, Samuel Z.
    Hernandez, Adrian F.
    Hull, Russell D.
    Cohen, Alexander T.
    Harrington, Robert A.
    Gibson, C. Michael
    [J]. CIRCULATION, 2018, 137 (01) : 91 - 94
  • [10] Effect of extended-duration thromboprophylaxis on venous thromboembolism and major bleeding among acutely ill hospitalized medical patients: a bivariate analysis
    Chi, G.
    Goldhaber, S. Z.
    Kittelson, J. M.
    Turpie, A. G. G.
    Hernandez, A. F.
    Hull, R. D.
    Gold, A.
    Curnutte, J. T.
    Cohen, A. T.
    Harrington, R. A.
    Gibson, C. M.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2017, 15 (10) : 1913 - 1922
12345